Datasets:
id int64 | detection_setting string | facility_id string | facility_type string | patient_age_years int64 | patient_age_group string | patient_sex string | patient_pregnant int64 | original_diagnosis string | sf_medicine_class string | sf_classification string | sf_confirmed_by_testing int64 | sf_source string | harm_type string | severity string | hospitalised int64 | hospital_days int64 | ICU_admission int64 | permanent_disability int64 | death int64 | treatment_failure int64 | time_to_harm_days int64 | time_to_detection_days int64 | economic_cost_direct_usd float64 | economic_cost_indirect_usd float64 | catastrophic_health_expenditure int64 | reported_to_authority int64 | legal_recourse int64 | compensation_received int64 | year int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | delayed | HARM_0027 | health_centre | 47 | adult | male | 0 | other | vaccine | falsified | 1 | informal_market | organ_damage_hepatotoxicity | fatal | 0 | 0 | 0 | 0 | 1 | 0 | 2 | 0 | 162.52 | 315.16 | 0 | 0 | 0 | 0 | 2,022 |
2 | delayed | HARM_0232 | home | 63 | elderly | male | 0 | TB | antimalarial | substandard | 0 | hospital_supply | pregnancy_adverse_outcome | moderate | 1 | 3 | 0 | 0 | 0 | 1 | 2 | 8 | 588.99 | 1,102.37 | 1 | 0 | 0 | 0 | 2,022 |
3 | delayed | HARM_0230 | home | 25 | adult | female | 0 | pneumonia | antimalarial | falsified | 0 | hospital_supply | death | severe | 0 | 0 | 0 | 0 | 0 | 1 | 7 | 13 | 91.07 | 121.36 | 0 | 0 | 0 | 0 | 2,023 |
4 | delayed | HARM_0249 | district_hospital | 0 | neonate | male | 0 | HIV | herbal_traditional | substandard | 1 | informal_market | acute_toxicity_poisoning | severe | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 206.11 | 271.75 | 0 | 0 | 0 | 0 | 2,023 |
5 | delayed | HARM_0215 | health_centre | 2 | child | male | 0 | HIV | ARV | substandard | 0 | formal_pharmacy | treatment_failure_disease_progression | fatal | 0 | 0 | 0 | 0 | 1 | 1 | 7 | 18 | 631.4 | 652.36 | 1 | 0 | 1 | 0 | 2,023 |
6 | delayed | HARM_0049 | district_hospital | 10 | school_age | male | 0 | pregnancy_complication | TB_medicine | falsified | 0 | online_purchase | antimicrobial_resistance_selection | severe | 1 | 2 | 0 | 1 | 0 | 0 | 6 | 2 | 1,128.42 | 1,021.92 | 1 | 0 | 0 | 0 | 2,023 |
7 | delayed | HARM_0134 | private_clinic | 0 | neonate | female | 0 | pain_fever | antimalarial | substandard | 0 | border_crossing | antimicrobial_resistance_selection | severe | 1 | 5 | 0 | 0 | 0 | 0 | 0 | 15 | 396.86 | 563.81 | 1 | 0 | 0 | 0 | 2,023 |
8 | delayed | HARM_0104 | district_hospital | 30 | adult | female | 0 | other | antibiotic | substandard | 0 | informal_market | death | life_threatening | 1 | 2 | 1 | 0 | 0 | 1 | 9 | 3 | 243.22 | 215.78 | 0 | 0 | 0 | 0 | 2,024 |
9 | delayed | HARM_0253 | home | 28 | adult | female | 0 | HIV | antimalarial | falsified | 0 | border_crossing | acute_toxicity_poisoning | mild | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 34 | 1,077.33 | 1,134.04 | 1 | 0 | 0 | 0 | 2,023 |
10 | delayed | HARM_0267 | tertiary_hospital | 4 | child | male | 0 | infection_other | antimalarial | substandard | 0 | online_purchase | treatment_failure_disease_progression | life_threatening | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 237.6 | 317.47 | 1 | 0 | 0 | 0 | 2,024 |
11 | delayed | HARM_0156 | home | 0 | neonate | female | 0 | malaria | antimalarial | substandard | 0 | online_purchase | neonatal_paediatric_harm | life_threatening | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 18 | 207.39 | 103.7 | 0 | 0 | 0 | 0 | 2,024 |
12 | delayed | HARM_0086 | private_clinic | 22 | adult | female | 0 | TB | antibiotic | substandard | 0 | donation | treatment_failure_disease_progression | mild | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 1 | 651.84 | 1,119.46 | 1 | 0 | 0 | 0 | 2,021 |
13 | delayed | HARM_0162 | tertiary_hospital | 0 | neonate | female | 0 | infection_other | paediatric_syrup | substandard | 0 | donation | death | mild | 1 | 3 | 0 | 0 | 0 | 0 | 5 | 0 | 143.74 | 301.22 | 0 | 1 | 0 | 0 | 2,020 |
14 | delayed | HARM_0007 | home | 61 | elderly | female | 0 | pain_fever | analgesic | falsified | 1 | informal_market | antimicrobial_resistance_selection | life_threatening | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 2 | 85.85 | 142.85 | 0 | 0 | 0 | 0 | 2,022 |
15 | delayed | HARM_0221 | health_centre | 43 | adult | female | 0 | hypertension | ARV | substandard | 0 | hospital_supply | death | severe | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 2 | 300.49 | 626.71 | 1 | 0 | 0 | 0 | 2,020 |
16 | delayed | HARM_0098 | home | 0 | neonate | female | 0 | diabetes | vaccine | falsified | 0 | informal_market | antimicrobial_resistance_selection | mild | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 12 | 446.49 | 685.82 | 1 | 0 | 0 | 0 | 2,023 |
17 | delayed | HARM_0042 | tertiary_hospital | 5 | school_age | female | 0 | TB | vaccine | falsified | 0 | donation | disability_permanent | moderate | 1 | 4 | 0 | 0 | 0 | 1 | 21 | 24 | 316.69 | 709.62 | 1 | 0 | 0 | 0 | 2,024 |
18 | delayed | HARM_0279 | health_centre | 28 | adult | female | 0 | malaria | herbal_traditional | substandard | 1 | online_purchase | prolonged_hospitalisation | mild | 0 | 0 | 0 | 0 | 0 | 1 | 19 | 3 | 497.52 | 876.68 | 1 | 0 | 0 | 0 | 2,024 |
19 | delayed | HARM_0014 | district_hospital | 47 | adult | female | 0 | infection_other | analgesic | substandard | 0 | formal_pharmacy | acute_toxicity_poisoning | mild | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 318.59 | 610.02 | 1 | 0 | 0 | 0 | 2,021 |
20 | delayed | HARM_0263 | home | 2 | child | female | 0 | pain_fever | anticonvulsant | falsified | 1 | formal_pharmacy | treatment_failure_disease_progression | severe | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 11 | 171.99 | 227.2 | 0 | 0 | 0 | 0 | 2,023 |
21 | delayed | HARM_0153 | private_clinic | 0 | neonate | female | 0 | pneumonia | antimalarial | substandard | 0 | informal_market | death | severe | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 33 | 821.98 | 1,096.73 | 1 | 0 | 0 | 0 | 2,023 |
22 | delayed | HARM_0017 | health_centre | 31 | adult | male | 0 | diarrhoea | ARV | substandard | 0 | online_purchase | organ_damage_nephrotoxicity | moderate | 1 | 6 | 0 | 0 | 0 | 1 | 3 | 2 | 847.87 | 863.94 | 1 | 0 | 0 | 0 | 2,023 |
23 | delayed | HARM_0176 | district_hospital | 48 | adult | male | 0 | epilepsy | ARV | substandard | 0 | donation | neonatal_paediatric_harm | severe | 0 | 0 | 0 | 0 | 0 | 1 | 8 | 6 | 571.3 | 1,047.07 | 1 | 0 | 1 | 0 | 2,022 |
24 | delayed | HARM_0196 | district_hospital | 4 | child | male | 0 | pain_fever | herbal_traditional | substandard | 1 | online_purchase | treatment_failure_disease_progression | moderate | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 19 | 100.4 | 135.67 | 0 | 0 | 1 | 0 | 2,023 |
25 | delayed | HARM_0140 | district_hospital | 49 | adult | female | 0 | pain_fever | injectable | substandard | 0 | informal_market | treatment_failure_disease_progression | life_threatening | 1 | 10 | 1 | 0 | 0 | 0 | 0 | 5 | 582.84 | 717.25 | 1 | 0 | 0 | 0 | 2,020 |
26 | delayed | HARM_0049 | district_hospital | 45 | adult | female | 0 | pain_fever | antimalarial | substandard | 0 | informal_market | death | severe | 0 | 0 | 0 | 0 | 0 | 0 | 25 | 13 | 153.26 | 134.53 | 0 | 0 | 0 | 0 | 2,021 |
27 | delayed | HARM_0007 | home | 22 | adult | male | 0 | pneumonia | antimalarial | falsified | 0 | informal_market | antimicrobial_resistance_selection | mild | 1 | 11 | 0 | 0 | 0 | 0 | 4 | 14 | 285.98 | 480.94 | 1 | 0 | 0 | 0 | 2,024 |
28 | delayed | HARM_0120 | home | 6 | school_age | male | 0 | diabetes | analgesic | falsified | 0 | informal_market | disability_permanent | life_threatening | 1 | 4 | 1 | 0 | 0 | 0 | 19 | 40 | 84.6 | 148.7 | 0 | 0 | 1 | 0 | 2,024 |
29 | delayed | HARM_0080 | home | 0 | neonate | male | 0 | malaria | anticonvulsant | falsified | 0 | donation | disability_permanent | life_threatening | 1 | 1 | 0 | 0 | 0 | 1 | 7 | 9 | 510.22 | 629.24 | 1 | 0 | 0 | 0 | 2,021 |
30 | delayed | HARM_0277 | home | 17 | adult | male | 0 | diabetes | paediatric_syrup | substandard | 0 | formal_pharmacy | treatment_failure_disease_progression | moderate | 0 | 0 | 0 | 0 | 0 | 0 | 18 | 9 | 312.41 | 564.72 | 1 | 0 | 0 | 0 | 2,023 |
31 | delayed | HARM_0019 | home | 24 | adult | male | 0 | malaria | antibiotic | substandard | 0 | online_purchase | organ_damage_hepatotoxicity | moderate | 0 | 0 | 0 | 0 | 0 | 0 | 16 | 11 | 89.43 | 61.9 | 0 | 0 | 0 | 0 | 2,024 |
32 | delayed | HARM_0118 | private_clinic | 22 | adult | male | 0 | diarrhoea | antibiotic | falsified | 0 | online_purchase | death | life_threatening | 1 | 9 | 0 | 0 | 0 | 0 | 35 | 34 | 238.57 | 452.19 | 1 | 0 | 0 | 0 | 2,024 |
33 | delayed | HARM_0234 | health_centre | 0 | neonate | male | 0 | malaria | antibiotic | substandard | 0 | informal_market | organ_damage_hepatotoxicity | mild | 1 | 1 | 0 | 1 | 0 | 0 | 6 | 0 | 293.16 | 534.65 | 1 | 1 | 0 | 0 | 2,024 |
34 | delayed | HARM_0154 | tertiary_hospital | 21 | adult | male | 0 | TB | vaccine | falsified | 0 | informal_market | acute_toxicity_poisoning | severe | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 142.92 | 246.38 | 0 | 0 | 1 | 0 | 2,024 |
35 | delayed | HARM_0027 | district_hospital | 0 | neonate | female | 0 | pneumonia | antidiabetic | substandard | 0 | formal_pharmacy | death | severe | 1 | 28 | 0 | 0 | 0 | 1 | 13 | 20 | 1,802.51 | 4,312.66 | 1 | 0 | 0 | 0 | 2,022 |
36 | delayed | HARM_0003 | community | 28 | adult | male | 0 | diarrhoea | antimalarial | substandard | 0 | formal_pharmacy | treatment_failure_disease_progression | life_threatening | 0 | 0 | 0 | 0 | 0 | 1 | 20 | 11 | 353.39 | 565.92 | 1 | 0 | 0 | 0 | 2,023 |
37 | delayed | HARM_0037 | tertiary_hospital | 5 | school_age | female | 0 | malaria | injectable | falsified | 0 | online_purchase | acute_toxicity_poisoning | mild | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 776.27 | 1,575.53 | 1 | 0 | 0 | 0 | 2,023 |
38 | delayed | HARM_0297 | private_clinic | 26 | adult | female | 0 | pain_fever | injectable | substandard | 0 | formal_pharmacy | death | severe | 1 | 1 | 0 | 0 | 0 | 1 | 4 | 1 | 140.67 | 177.16 | 0 | 0 | 0 | 0 | 2,024 |
39 | delayed | HARM_0073 | health_centre | 45 | adult | male | 0 | hypertension | TB_medicine | falsified | 0 | online_purchase | treatment_failure_disease_progression | life_threatening | 0 | 0 | 0 | 0 | 0 | 1 | 4 | 3 | 267.52 | 656.1 | 1 | 0 | 0 | 0 | 2,024 |
40 | delayed | HARM_0064 | health_centre | 19 | adult | female | 0 | diabetes | injectable | substandard | 1 | informal_market | organ_damage_nephrotoxicity | mild | 1 | 1 | 0 | 0 | 0 | 0 | 7 | 2 | 334.02 | 515.06 | 1 | 0 | 0 | 0 | 2,021 |
41 | delayed | HARM_0144 | health_centre | 3 | child | female | 0 | other | analgesic | substandard | 1 | informal_market | acute_toxicity_poisoning | life_threatening | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 7 | 145.95 | 240.01 | 0 | 0 | 0 | 0 | 2,020 |
42 | delayed | HARM_0157 | home | 23 | adult | male | 0 | diarrhoea | antibiotic | falsified | 0 | hospital_supply | acute_toxicity_poisoning | moderate | 1 | 9 | 0 | 0 | 0 | 1 | 3 | 4 | 292.24 | 251.76 | 1 | 0 | 0 | 0 | 2,021 |
43 | delayed | HARM_0195 | health_centre | 5 | school_age | female | 0 | pregnancy_complication | ARV | substandard | 1 | formal_pharmacy | treatment_failure_disease_progression | fatal | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 3 | 487.34 | 674.41 | 1 | 0 | 0 | 0 | 2,024 |
44 | delayed | HARM_0124 | health_centre | 65 | elderly | female | 0 | pneumonia | antibiotic | substandard | 1 | border_crossing | organ_damage_hepatotoxicity | severe | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15 | 88.16 | 152.15 | 0 | 0 | 0 | 0 | 2,020 |
45 | delayed | HARM_0279 | community | 24 | adult | female | 0 | other | paediatric_syrup | substandard | 1 | border_crossing | acute_toxicity_poisoning | mild | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 4 | 573.29 | 573.37 | 1 | 0 | 0 | 0 | 2,023 |
46 | delayed | HARM_0103 | private_clinic | 26 | adult | male | 0 | pneumonia | anticonvulsant | falsified | 1 | informal_market | neonatal_paediatric_harm | life_threatening | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 5 | 1,470.61 | 3,172.7 | 1 | 0 | 0 | 0 | 2,024 |
47 | delayed | HARM_0177 | home | 24 | adult | male | 0 | HIV | paediatric_syrup | substandard | 1 | hospital_supply | prolonged_hospitalisation | severe | 1 | 3 | 0 | 0 | 0 | 0 | 14 | 3 | 154.64 | 235.99 | 0 | 0 | 0 | 0 | 2,022 |
48 | delayed | HARM_0153 | community | 66 | elderly | female | 0 | infection_other | injectable | substandard | 0 | online_purchase | organ_damage_hepatotoxicity | fatal | 1 | 6 | 1 | 0 | 1 | 0 | 24 | 17 | 666.79 | 1,226.03 | 1 | 0 | 0 | 0 | 2,023 |
49 | delayed | HARM_0133 | district_hospital | 1 | infant | female | 0 | pain_fever | injectable | falsified | 0 | hospital_supply | allergic_anaphylactic_reaction | severe | 1 | 12 | 0 | 0 | 0 | 1 | 11 | 2 | 1,120.1 | 1,424.5 | 1 | 0 | 0 | 0 | 2,020 |
50 | delayed | HARM_0190 | district_hospital | 49 | adult | male | 0 | pain_fever | antimalarial | substandard | 0 | formal_pharmacy | treatment_failure_disease_progression | moderate | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 494.73 | 757.41 | 1 | 0 | 0 | 0 | 2,021 |
51 | delayed | HARM_0213 | district_hospital | 23 | adult | female | 0 | infection_other | injectable | falsified | 0 | formal_pharmacy | disability_permanent | fatal | 1 | 6 | 0 | 1 | 1 | 0 | 3 | 4 | 118.31 | 130.46 | 0 | 0 | 0 | 0 | 2,024 |
52 | delayed | HARM_0249 | home | 24 | adult | male | 0 | pregnancy_complication | antimalarial | substandard | 0 | formal_pharmacy | treatment_failure_disease_progression | mild | 1 | 12 | 0 | 1 | 0 | 0 | 12 | 2 | 287.96 | 143.98 | 0 | 0 | 0 | 0 | 2,024 |
53 | delayed | HARM_0013 | health_centre | 45 | adult | female | 0 | pain_fever | paediatric_syrup | substandard | 1 | formal_pharmacy | disability_permanent | mild | 1 | 1 | 0 | 0 | 0 | 0 | 7 | 10 | 223.35 | 412.95 | 1 | 0 | 0 | 0 | 2,024 |
54 | delayed | HARM_0028 | home | 0 | neonate | female | 0 | diarrhoea | TB_medicine | substandard | 0 | donation | prolonged_hospitalisation | mild | 1 | 3 | 0 | 0 | 0 | 1 | 7 | 5 | 97.3 | 108.88 | 0 | 0 | 0 | 0 | 2,023 |
55 | delayed | HARM_0049 | private_clinic | 46 | adult | male | 0 | pneumonia | injectable | substandard | 1 | donation | allergic_anaphylactic_reaction | severe | 0 | 0 | 0 | 1 | 0 | 1 | 5 | 3 | 166.79 | 374.02 | 1 | 0 | 0 | 0 | 2,022 |
56 | delayed | HARM_0095 | district_hospital | 0 | neonate | male | 0 | HIV | antimalarial | substandard | 0 | online_purchase | acute_toxicity_poisoning | life_threatening | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 16 | 134.51 | 290.87 | 0 | 0 | 0 | 0 | 2,023 |
57 | delayed | HARM_0043 | tertiary_hospital | 27 | adult | female | 0 | pain_fever | antibiotic | falsified | 0 | informal_market | drug_interaction_toxicity | moderate | 1 | 9 | 0 | 0 | 0 | 1 | 2 | 2 | 972.16 | 971.53 | 1 | 0 | 0 | 0 | 2,022 |
58 | delayed | HARM_0299 | private_clinic | 59 | elderly | male | 0 | diarrhoea | paediatric_syrup | substandard | 0 | hospital_supply | antimicrobial_resistance_selection | moderate | 1 | 11 | 0 | 0 | 0 | 1 | 9 | 3 | 661.53 | 844.39 | 1 | 0 | 0 | 0 | 2,024 |
59 | delayed | HARM_0291 | private_clinic | 49 | adult | female | 0 | HIV | injectable | substandard | 1 | formal_pharmacy | prolonged_hospitalisation | severe | 1 | 9 | 0 | 0 | 0 | 0 | 9 | 0 | 427.64 | 357.85 | 1 | 0 | 0 | 0 | 2,023 |
60 | delayed | HARM_0278 | district_hospital | 0 | neonate | female | 0 | hypertension | injectable | falsified | 0 | formal_pharmacy | antimicrobial_resistance_selection | life_threatening | 1 | 5 | 0 | 0 | 0 | 0 | 3 | 25 | 265.05 | 241.2 | 1 | 0 | 0 | 0 | 2,022 |
61 | delayed | HARM_0212 | home | 1 | infant | female | 0 | infection_other | antibiotic | falsified | 0 | online_purchase | treatment_failure_disease_progression | severe | 0 | 0 | 0 | 0 | 0 | 1 | 3 | 5 | 148.13 | 287.12 | 0 | 0 | 0 | 0 | 2,024 |
62 | delayed | HARM_0091 | tertiary_hospital | 33 | adult | female | 0 | TB | antimalarial | substandard | 0 | border_crossing | treatment_failure_disease_progression | severe | 1 | 23 | 0 | 1 | 0 | 0 | 28 | 3 | 623.55 | 1,531.74 | 1 | 0 | 0 | 0 | 2,024 |
63 | delayed | HARM_0261 | health_centre | 27 | adult | female | 0 | pneumonia | antibiotic | falsified | 1 | donation | prolonged_hospitalisation | life_threatening | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 22 | 546.1 | 867.55 | 1 | 0 | 0 | 0 | 2,024 |
64 | delayed | HARM_0170 | health_centre | 24 | adult | male | 0 | HIV | antimalarial | substandard | 0 | informal_market | neonatal_paediatric_harm | severe | 1 | 1 | 0 | 0 | 0 | 0 | 2 | 3 | 554.67 | 441.01 | 1 | 0 | 1 | 0 | 2,020 |
65 | delayed | HARM_0045 | private_clinic | 66 | elderly | female | 0 | pneumonia | vaccine | substandard | 0 | border_crossing | organ_damage_hepatotoxicity | mild | 1 | 6 | 0 | 0 | 0 | 1 | 44 | 11 | 478.36 | 1,052.68 | 1 | 0 | 0 | 0 | 2,022 |
66 | delayed | HARM_0059 | district_hospital | 47 | adult | female | 0 | pneumonia | antimalarial | substandard | 0 | informal_market | organ_damage_nephrotoxicity | fatal | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 29 | 1,106.43 | 1,579.97 | 1 | 1 | 0 | 0 | 2,023 |
67 | delayed | HARM_0148 | health_centre | 1 | infant | female | 0 | pain_fever | paediatric_syrup | substandard | 0 | online_purchase | organ_damage_hepatotoxicity | severe | 0 | 0 | 0 | 0 | 0 | 1 | 10 | 9 | 361.46 | 309.7 | 1 | 0 | 0 | 0 | 2,024 |
68 | delayed | HARM_0269 | tertiary_hospital | 2 | child | female | 0 | pregnancy_complication | antibiotic | substandard | 0 | formal_pharmacy | treatment_failure_disease_progression | moderate | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 4 | 706.54 | 574.77 | 1 | 0 | 0 | 0 | 2,022 |
69 | delayed | HARM_0115 | private_clinic | 43 | adult | female | 0 | infection_other | herbal_traditional | substandard | 0 | formal_pharmacy | organ_damage_hepatotoxicity | moderate | 0 | 0 | 0 | 0 | 0 | 1 | 17 | 8 | 389.09 | 596.85 | 1 | 0 | 0 | 0 | 2,022 |
70 | delayed | HARM_0039 | district_hospital | 42 | adult | female | 0 | pregnancy_complication | injectable | substandard | 0 | border_crossing | death | severe | 1 | 1 | 0 | 0 | 0 | 0 | 3 | 9 | 767.48 | 704.23 | 1 | 0 | 0 | 0 | 2,024 |
71 | delayed | HARM_0021 | home | 44 | adult | male | 0 | HIV | antibiotic | substandard | 0 | informal_market | antimicrobial_resistance_selection | moderate | 1 | 1 | 0 | 1 | 0 | 0 | 2 | 7 | 211.71 | 240.44 | 0 | 0 | 0 | 0 | 2,022 |
72 | delayed | HARM_0254 | home | 0 | neonate | female | 0 | pneumonia | antibiotic | falsified | 0 | informal_market | organ_damage_nephrotoxicity | moderate | 0 | 0 | 0 | 0 | 0 | 1 | 18 | 3 | 358.34 | 721.84 | 1 | 0 | 1 | 0 | 2,023 |
73 | delayed | HARM_0218 | tertiary_hospital | 20 | adult | male | 0 | pneumonia | antibiotic | substandard | 0 | donation | prolonged_hospitalisation | severe | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 17 | 866.17 | 1,846.91 | 1 | 0 | 0 | 0 | 2,023 |
74 | delayed | HARM_0243 | district_hospital | 44 | adult | female | 0 | diarrhoea | antibiotic | substandard | 0 | informal_market | acute_toxicity_poisoning | life_threatening | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 7 | 1,249.25 | 2,108.15 | 1 | 0 | 0 | 0 | 2,023 |
75 | delayed | HARM_0161 | tertiary_hospital | 48 | adult | female | 0 | TB | herbal_traditional | substandard | 0 | donation | disability_permanent | moderate | 1 | 2 | 0 | 0 | 0 | 0 | 7 | 15 | 200.86 | 250.41 | 0 | 0 | 0 | 0 | 2,023 |
76 | delayed | HARM_0228 | health_centre | 4 | child | female | 0 | infection_other | injectable | falsified | 0 | online_purchase | allergic_anaphylactic_reaction | fatal | 1 | 1 | 0 | 0 | 1 | 0 | 6 | 8 | 389.96 | 672.69 | 1 | 0 | 0 | 0 | 2,023 |
77 | delayed | HARM_0088 | home | 0 | neonate | female | 0 | diabetes | antihypertensive | substandard | 0 | donation | treatment_failure_disease_progression | moderate | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 6 | 228.7 | 200.22 | 0 | 0 | 0 | 0 | 2,021 |
78 | delayed | HARM_0197 | district_hospital | 0 | neonate | female | 0 | epilepsy | TB_medicine | substandard | 0 | informal_market | prolonged_hospitalisation | moderate | 0 | 0 | 0 | 0 | 0 | 1 | 7 | 3 | 155.68 | 243.37 | 0 | 0 | 0 | 0 | 2,021 |
79 | delayed | HARM_0087 | tertiary_hospital | 0 | neonate | female | 0 | malaria | antimalarial | falsified | 0 | hospital_supply | prolonged_hospitalisation | life_threatening | 0 | 0 | 0 | 0 | 0 | 0 | 11 | 3 | 117.13 | 164.59 | 0 | 0 | 0 | 0 | 2,021 |
80 | delayed | HARM_0064 | district_hospital | 41 | adult | female | 0 | malaria | vaccine | substandard | 1 | hospital_supply | neonatal_paediatric_harm | moderate | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 7 | 153.45 | 235.58 | 0 | 0 | 0 | 0 | 2,023 |
81 | delayed | HARM_0183 | health_centre | 21 | adult | male | 0 | TB | TB_medicine | substandard | 0 | informal_market | disability_permanent | severe | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 9 | 142.71 | 318.41 | 0 | 1 | 0 | 0 | 2,023 |
82 | delayed | HARM_0023 | home | 28 | adult | female | 0 | pneumonia | antibiotic | substandard | 1 | informal_market | disability_permanent | life_threatening | 1 | 2 | 1 | 0 | 0 | 1 | 7 | 5 | 274.35 | 355.33 | 1 | 0 | 0 | 0 | 2,024 |
83 | delayed | HARM_0283 | community | 39 | adult | male | 0 | diarrhoea | antibiotic | substandard | 0 | border_crossing | drug_interaction_toxicity | severe | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 11 | 173.16 | 318.08 | 0 | 0 | 0 | 0 | 2,024 |
84 | delayed | HARM_0150 | home | 45 | adult | male | 0 | hypertension | antidiabetic | substandard | 0 | informal_market | disability_permanent | moderate | 1 | 2 | 0 | 0 | 0 | 0 | 2 | 3 | 359.28 | 338.03 | 1 | 1 | 0 | 0 | 2,021 |
85 | delayed | HARM_0077 | district_hospital | 1 | infant | female | 0 | malaria | herbal_traditional | substandard | 0 | informal_market | organ_damage_nephrotoxicity | mild | 0 | 0 | 0 | 0 | 0 | 1 | 5 | 5 | 260.16 | 420.88 | 1 | 0 | 0 | 0 | 2,024 |
86 | delayed | HARM_0197 | private_clinic | 59 | elderly | male | 0 | hypertension | ARV | substandard | 1 | informal_market | prolonged_hospitalisation | mild | 1 | 5 | 0 | 0 | 0 | 0 | 43 | 19 | 794.37 | 880.49 | 1 | 0 | 0 | 0 | 2,020 |
87 | delayed | HARM_0259 | health_centre | 23 | adult | female | 0 | pneumonia | injectable | substandard | 0 | border_crossing | treatment_failure_disease_progression | life_threatening | 0 | 0 | 0 | 0 | 0 | 0 | 11 | 1 | 33.93 | 71.09 | 0 | 0 | 0 | 0 | 2,023 |
88 | delayed | HARM_0067 | district_hospital | 41 | adult | female | 0 | hypertension | antihypertensive | substandard | 0 | hospital_supply | organ_damage_hepatotoxicity | moderate | 1 | 4 | 0 | 0 | 0 | 0 | 4 | 3 | 340.8 | 313.21 | 1 | 0 | 0 | 0 | 2,024 |
89 | delayed | HARM_0038 | community | 63 | elderly | male | 0 | infection_other | ARV | substandard | 0 | hospital_supply | acute_toxicity_poisoning | moderate | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14 | 278.34 | 335.95 | 1 | 0 | 0 | 0 | 2,021 |
90 | delayed | HARM_0078 | district_hospital | 46 | adult | male | 0 | malaria | paediatric_syrup | substandard | 0 | informal_market | treatment_failure_disease_progression | severe | 1 | 9 | 0 | 0 | 0 | 1 | 5 | 12 | 401.19 | 489.36 | 1 | 0 | 0 | 0 | 2,023 |
91 | delayed | HARM_0044 | health_centre | 7 | school_age | male | 0 | pain_fever | injectable | substandard | 0 | hospital_supply | acute_toxicity_poisoning | life_threatening | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 495.29 | 805.31 | 1 | 0 | 0 | 0 | 2,020 |
92 | delayed | HARM_0007 | health_centre | 46 | adult | female | 0 | other | paediatric_syrup | substandard | 1 | border_crossing | acute_toxicity_poisoning | severe | 1 | 9 | 0 | 0 | 0 | 0 | 3 | 8 | 330.99 | 275.8 | 1 | 0 | 0 | 0 | 2,024 |
93 | delayed | HARM_0258 | health_centre | 63 | elderly | male | 0 | malaria | paediatric_syrup | substandard | 0 | formal_pharmacy | prolonged_hospitalisation | moderate | 1 | 4 | 0 | 0 | 0 | 0 | 1 | 19 | 593.65 | 1,038.27 | 1 | 0 | 0 | 0 | 2,020 |
94 | delayed | HARM_0117 | health_centre | 9 | school_age | female | 0 | malaria | vaccine | falsified | 0 | hospital_supply | prolonged_hospitalisation | fatal | 1 | 1 | 0 | 0 | 1 | 1 | 12 | 0 | 535.12 | 750.24 | 1 | 1 | 0 | 0 | 2,021 |
95 | delayed | HARM_0101 | tertiary_hospital | 0 | neonate | male | 0 | HIV | ARV | substandard | 1 | formal_pharmacy | treatment_failure_disease_progression | life_threatening | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 4 | 508.87 | 812.95 | 1 | 0 | 0 | 0 | 2,022 |
96 | delayed | HARM_0082 | community | 47 | adult | female | 0 | malaria | injectable | falsified | 1 | hospital_supply | treatment_failure_disease_progression | life_threatening | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 4 | 478.33 | 836.2 | 1 | 0 | 0 | 0 | 2,022 |
97 | delayed | HARM_0255 | home | 3 | child | male | 0 | diarrhoea | antihypertensive | substandard | 0 | informal_market | treatment_failure_disease_progression | moderate | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 258.66 | 429.9 | 1 | 0 | 0 | 0 | 2,023 |
98 | delayed | HARM_0128 | district_hospital | 48 | adult | male | 0 | other | antimalarial | substandard | 0 | formal_pharmacy | antimicrobial_resistance_selection | life_threatening | 1 | 1 | 1 | 0 | 0 | 1 | 35 | 16 | 566.06 | 943.21 | 1 | 0 | 0 | 0 | 2,022 |
99 | delayed | HARM_0141 | tertiary_hospital | 66 | elderly | female | 0 | hypertension | injectable | substandard | 1 | border_crossing | pregnancy_adverse_outcome | moderate | 1 | 14 | 0 | 0 | 0 | 1 | 7 | 1 | 514.27 | 901.96 | 1 | 1 | 0 | 0 | 2,022 |
100 | delayed | HARM_0047 | community | 0 | neonate | female | 0 | pregnancy_complication | antimalarial | substandard | 0 | informal_market | acute_toxicity_poisoning | mild | 1 | 3 | 0 | 0 | 0 | 1 | 1 | 6 | 294.66 | 322.15 | 1 | 0 | 0 | 0 | 2,022 |
End of preview. Expand
in Data Studio
Patient Harm from Substandard Medicines Dataset
Abstract
30,000 simulated patient harm observations (10,000 per scenario) across three detection/resource levels. Variables include harm type, severity, hospitalisation, mortality, treatment failure, economic burden, SF medicine class and source, and legal recourse. Three scenarios: early detection (2% mortality, 49% catastrophic expenditure), delayed (8%, 74%), undetected (18%, 87%).
This dataset is entirely simulated. It must not be used for clinical or legal decisions.
Validation
Usage
from datasets import load_dataset
dataset = load_dataset("electricsheepafrica/patient-harm-substandard-medicines", "moderate_resource_delayed")
df = dataset["train"].to_pandas()
print(df.groupby('severity')['death'].mean())
References
- WHO (2017). 116,000 additional malaria deaths from SF antimalarials.
- WHO (2024). SF medicines and patient harm.
- Lancet (2019). DEG contamination — paediatric cough syrup poisoning.
- BMJ Global Health (2020). Economic burden of SF medicines.
Citation
@dataset{esa_patient_harm_2025,
title = {Patient Harm from Substandard Medicines Dataset},
author = {{Electric Sheep Africa}},
year = {2025},
publisher = {Hugging Face},
url = {https://huggingface.co/datasets/electricsheepafrica/patient-harm-substandard-medicines}
}
License
- Downloads last month
- 464